GENETHON III has a total of 11 patent applications. Its first patent ever was published in 1998. It filed its patents most often in France, EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are OLSON ERIC, SYNAGEVA BIOPHARMA CORP and ARNOULD SYLVAIN.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Animal care | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Soudais Claire | 3 |
#2 | Boutin Sylvie | 3 |
#3 | Vincent Nathalie | 3 |
#4 | Kremer Eric | 3 |
#5 | Peltekian Elise | 3 |
#6 | Lamartine Jerome | 3 |
#7 | Danos Olivier | 3 |
#8 | Waksman Gilles | 3 |
#9 | Garcia Luis | 3 |
#10 | Chillon Rodriguez Miguel | 3 |
Publication | Filing date | Title |
---|---|---|
FR2832424A1 | Chimeric plasmid comprising a replicative retroviral genome and uses | |
FR2826656A1 | Method for detecting the activity of calpain 3 in a biological sample and peptides for the implementation of said method | |
FR2825364A1 | PEPTIIDIC VECTOR FOR THE TRANSFER OF NUCLEIC ACIDS IN EUKARYOTIC CELLS | |
EP1248851A2 | Canine adenovirus vectors for the transfer of genes in targeted cells | |
FR2814753A1 | Uses of the gjb6 gene in the treatment of certain alopecia, including clouston syndrome, and in the screening of compounds likely to be effective in the treatment of gene predisposition alopecia | |
EP1118670A1 | Canine adenovirus vectors for the transfer of genes in targeted cells | |
EP1007558A1 | Familial mediterranean fever gene |